Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Transaction in Own Shares

2nd Dec 2025 07:00

RNS Number : 7853J
CVS Group plc
02 December 2025
 

02 December 2025

 

CVS GROUP plc

("CVS" or the "Company" and, together with its subsidiaries, the "Group")

Transaction in own shares

 

CVS announces that on 01 December 2025 it purchased the following number of its ordinary shares of 0.2 pence each ("Ordinary Shares") from Joh. Berenberg, Gossler & Co. KG, London Branch ("Berenberg"), in accordance with the terms of the share buyback programme announced on 24 October 2025 (the "Share Buyback Programme").

 

Date of purchase:

01/12/2025

Aggregate number of Ordinary Shares purchased:

24,380

Lowest price paid per share (GBp):

1,216.00

Highest price paid per share (GBp):

1,230.00

Volume weighted average price paid per share (GBp):

1,221.26

CVS intends to cancel all of the purchased Ordinary Shares.

 

Following settlement of the above purchases and cancellation of the Ordinary Shares purchased, CVS will have 71,038,131 Ordinary Shares in issue and holds no Ordinary Shares in treasury.

 

The total number of voting rights in CVS is therefore 71,038,131 and this figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, CVS under the Financial Conduct Authority's Disclosure and Transparency Rules.

 

Since the commencement of the Share Buyback Programme, the Company has repurchased 702,652 Ordinary Shares in aggregate at a weighted average price of 1,215.70 pence per share.

 

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the Market Abuse Regulation), as it forms part of Retained EU Law as defined in the European Union (Withdrawal) Act 2018, the table below contains detailed information of the individual trades made by Berenberg as part of the Share Buyback Programme.

 

Individual transactions:

 

Number of

Ordinary Shares purchased

Transaction price (GBp share)

Time of

transaction (UK Time)

Transaction

reference number

Trading Venue

 

460

1220

01/12/2025 08:18:20

1343423437085083

XLON

577

1218

01/12/2025 08:30:00

1343423437086574

XLON

257

1218

01/12/2025 09:02:05

1343423437089975

XLON

803

1220

01/12/2025 09:35:00

1343423437093273

XLON

288

1220

01/12/2025 09:36:11

1343423437093342

XLON

219

1220

01/12/2025 09:36:11

1343423437093343

XLON

331

1218

01/12/2025 09:43:40

1343423437093795

XLON

436

1218

01/12/2025 09:55:18

1343423437094684

XLON

112

1218

01/12/2025 09:56:01

1343423437094744

XLON

662

1222

01/12/2025 10:42:12

1343423437097500

XLON

94

1222

01/12/2025 10:42:12

1343423437097501

XLON

577

1220

01/12/2025 10:47:30

1343423437097853

XLON

120

1220

01/12/2025 10:47:33

1343423437097854

XLON

248

1220

01/12/2025 10:53:56

1343423437098182

XLON

294

1216

01/12/2025 10:54:06

1343423437098186

XLON

179

1216

01/12/2025 10:54:06

1343423437098187

XLON

735

1218

01/12/2025 11:05:05

1343423437098948

XLON

257

1218

01/12/2025 11:05:05

1343423437098950

XLON

478

1218

01/12/2025 11:05:05

1343423437098951

XLON

732

1218

01/12/2025 11:06:54

1343423437099051

XLON

732

1220

01/12/2025 11:13:09

1343423437099505

XLON

71

1218

01/12/2025 11:13:15

1343423437099509

XLON

71

1218

01/12/2025 11:13:21

1343423437099513

XLON

560

1220

01/12/2025 11:21:06

1343423437100114

XLON

771

1224

01/12/2025 12:05:48

1343423437103984

XLON

131

1222

01/12/2025 12:31:53

1343423437105501

XLON

80

1222

01/12/2025 12:31:53

1343423437105502

XLON

816

1220

01/12/2025 12:55:00

1343423437107024

XLON

826

1220

01/12/2025 12:55:00

1343423437107032

XLON

826

1218

01/12/2025 12:55:47

1343423437107085

XLON

71

1218

01/12/2025 13:01:19

1343423437107463

XLON

288

1224

01/12/2025 13:18:04

1343423437108804

XLON

200

1222

01/12/2025 13:45:07

1343423437111282

XLON

400

1222

01/12/2025 13:45:08

1343423437111283

XLON

41

1220

01/12/2025 13:50:26

1343423437111694

XLON

922

1220

01/12/2025 13:50:26

1343423437111695

XLON

200

1218

01/12/2025 13:50:32

1343423437111709

XLON

200

1218

01/12/2025 13:51:03

1343423437111754

XLON

971

1216

01/12/2025 13:52:00

1343423437111856

XLON

995

1216

01/12/2025 13:52:00

1343423437111857

XLON

559

1218

01/12/2025 13:52:58

1343423437111941

XLON

158

1218

01/12/2025 13:52:58

1343423437111942

XLON

1161

1220

01/12/2025 13:54:42

1343423437112080

XLON

653

1230

01/12/2025 15:34:26

1343423437128374

XLON

1

1230

01/12/2025 15:34:26

1343423437128375

XLON

64

1230

01/12/2025 15:34:31

1343423437128382

XLON

11

1230

01/12/2025 15:34:31

1343423437128383

XLON

1187

1228

01/12/2025 15:50:19

1343423437131054

XLON

84

1228

01/12/2025 15:50:21

1343423437131064

XLON

50

1228

01/12/2025 15:50:21

1343423437131065

XLON

7

1228

01/12/2025 15:50:21

1343423437131066

XLON

306

1228

01/12/2025 15:50:23

1343423437131070

XLON

330

1228

01/12/2025 15:59:41

1343423437132940

XLON

103

1228

01/12/2025 15:59:41

1343423437132945

XLON

111

1228

01/12/2025 15:59:41

1343423437132944

XLON

119

1228

01/12/2025 15:59:41

1343423437132943

XLON

158

1228

01/12/2025 15:59:41

1343423437132942

XLON

119

1228

01/12/2025 15:59:41

1343423437132941

XLON

8

1228

01/12/2025 16:01:24

1343423437133540

XLON

96

1228

01/12/2025 16:08:02

1343423437134985

XLON

191

1228

01/12/2025 16:08:02

1343423437134984

XLON

313

1228

01/12/2025 16:09:03

1343423437135203

XLON

199

1228

01/12/2025 16:09:03

1343423437135206

XLON

471

1228

01/12/2025 16:09:03

1343423437135204

XLON

24

1228

01/12/2025 16:09:03

1343423437135207

XLON

175

1228

01/12/2025 16:09:09

1343423437135224

XLON

270

1228

01/12/2025 16:15:03

1343423437136545

XLON

421

1228

01/12/2025 16:15:03

1343423437136546

XLON

 

 

Contacts

CVS Group plc via Camarco

Richard Fairman, CEO

Robin Alfonso, CFO

Paul Higgs, Chief Veterinary Officer

Charlotte Page, Head of Investor Relations

 

Peel Hunt LLP (Nominated Adviser & Joint Broker) +44 (0)20 7418 8900

Christopher Golden / James Steel / Andrew Clark

 

Berenberg (Joint Broker) +44 (0)20 3207 7800

Toby Flaux / Michael Burke / Milo Bonser / Brooke Harris-Lowing

 

Camarco (Financial PR) [email protected]

Ginny Pulbrook +44 (0)7961 315 138

Letaba Rimell

Tilly Butcher

 

About CVS Group plc (www.cvsukltd.co.uk)

 

CVS Group is an AIM-listed provider of veterinary services with operations in the UK and Australia. CVS is focused on providing high-quality clinical services to its clients and their animals, with outstanding and dedicated clinical teams and support colleagues at the core of its strategy.

 

The Group now operates c.470 veterinary practices across its two territories, including specialist referral hospitals and dedicated out-of-hours sites. Alongside the core Veterinary Practices division, CVS operates Laboratories (providing diagnostic services to CVS and third-parties) and an online retail business ("Animed Direct").

 

The Group employs c.8,900 personnel, including c.2,400 veterinary surgeons and c.3,300 nurses.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSUPGPCPUPAPWG

Related Shares:

CVS Group
FTSE 100 Latest
Value9,642.01
Change-3.08